Showing results (2231-2240 of 2,270) with videos related to

Sort By:
Pageof 227
JAMA Network Open|December 29, 2021
Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysisTing Martin Ma, Tahmineh Romero, Nicholas G Nickols, et al.
JAMA Oncology|May 24, 2019
Association of Black Race With Prostate Cancer-Specific and Other-Cause MortalityRobert T Dess, Holly E Hartman, Brandon A Mahal, et al.
The Lancet. Oncology|March 20, 2025
Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortiumAmar U Kishan, Yilun Sun, Alison C Tree, et al.
Cancer Immunology Research|April 16, 2017
Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLCPaul C Tumeh, Matthew D Hellmann, Omid Hamid, et al.
JAMA Oncology|March 28, 2020
Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate CancerRobert T Dess, Yilun Sun, William C Jackson, et al.
Nature Cancer|February 5, 2022
Immune-stimulating antibody conjugates elicit robust myeloid activation and durable antitumor immunityShelley E Ackerman, Cecelia I Pearson, Joshua D Gregorio, et al.
Cell|June 9, 2023
High-resolution analyses of associations between medications, microbiome, and mortality in cancer patientsChi L Nguyen, Kate A Markey, Oriana Miltiadous, et al.
Lancet (London, England)|March 1, 2026
Hormone therapy use and duration with postoperative radiotherapy for recurrent prostate cancer: an individual patient data meta-analysisAmar U Kishan, Yilun Sun, Christopher C Parker, et al.
European Urology|July 28, 2026
Influence of Adverse Pathologic Features on Potential Benefit of Hormone Therapy Use with Postoperative Radiotherapy in Recurrent Prostate Cancer: An Individual Patient Data Meta-analysisAmar U Kishan, Yilun Sun, Christopher C Parker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2025
Accelerating Drug Development in Hormone-Naïve Prostate Cancer Through Multi-Modal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical TrialDeaglan McHugh, Matthew Dallos, Min Yuen Teo, et al.
Pageof 227